Drug Shortage Report for DEXTROSE INJECTION USP
Report ID | 160928 |
Drug Identification Number | 02468514 |
Brand name | DEXTROSE INJECTION USP |
Common or Proper name | DEXTROSE INJECTION USP |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | DEXTROSE |
Strength(s) | 500MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 10 x 50mL LifeShield syringes |
ATC code | B05BA |
ATC description | I.V. SOLUTIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-05-18 |
Estimated end date | |
Actual end date | 2022-08-30 |
Shortage status | Resolved |
Updated date | 2022-08-31 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2022-08-31 | French | Compare |
v6 | 2022-08-31 | English | Compare |
v5 | 2022-06-22 | French | Compare |
v4 | 2022-06-22 | English | Compare |
v3 | 2022-05-19 | French | Compare |
v2 | 2022-05-19 | English | Compare |
v1 | 2022-05-19 | English | Compare |
Showing 1 to 7 of 7